iOS app Android app


Lessons from Roche's NJ Exit: Taxes Aren't the Magic Bullet for Job Creation

Gordon MacInnes | Posted 09.05.2012 | Business
Gordon MacInnes

Not even the loss of 1,000 high-paying jobs as Roche abandons its 80-year tie to New Jersey is enough to shake the one-note insistence of Gov. Chris Christie's administration that taxes are all that counts in holding and attracting jobs.

Courts Rule Stanford And Pharma Giant Co-Owners Of HIV Patent

AP | Posted 08.06.2011 | College

WASHINGTON — Ownership of a patent for technology to detect HIV levels in patients' blood was correctly split between Stanford University and th...

Cloud Architecture

Carla Leitao | Posted 04.16.2012 | Arts
Carla Leitao

In our office we are interested in creating a framework by which the word 'technology' can indeed be engaged through its practical corollaries -- communication and material -- in the creation of architectural and urban space.

Supreme Court To Decide University Patent Case

AP | Posted 05.25.2011 | College

WASHINGTON — The Supreme Court will decide whether patents on inventions that arise from federally-funded research must go to the university where t...

22 Republicans, 20 Democrats Used Lobbying Firm's Statements In House Health Care Speeches

New York Times | ROBERT PEAR | Posted 05.25.2011 | Politics

Statements by more than a dozen lawmakers were ghostwritten, in whole or in part, by Washington lobbyists working for Genentech, one of the world's la...

The Possiblity of a Pandemic and the Certainty of Diseases That Kill

Richard Chin | Posted 05.25.2011 | World
Richard Chin

Diarrheal diseases, which kill approximately 2 million children under the age of five in every year continue to receive less attention than diseases like the swine flu virus.

Thinking the Unthinkable: Six (Uncomfortable) Questions about the Swine Flu Outbreak

Ben Sherwood | Posted 05.25.2011 | World
Ben Sherwood

Are there enough antiviral medicines to keep us safe? Do face masks protect against swine flu? Is the world ready for a new pandemic?

Roche To Take Over Genentech For $47 Billion

AP | ALEXANDER G. HIGGINS | Posted 05.25.2011 | Business

GENEVA — Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already...

The 10 Worst Corporations of 2008

Robert Weissman | Posted 05.25.2011 | Business
Robert Weissman

In keeping with our tradition of highlighting diverse forms of corporate wrongdoing, we included only one financial company on the 10 Worst list.

Top European Drugmakers Back Stem Cell Testing

Reuters | Ben Hirschler | Posted 05.25.2011 | Business

Three of Europe's top drugmakers have backed a new public-private scheme to use stem cells for safety testing of experimental medicines, signaling "bi...